Everence Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,260
| Closed | -$221K | – | 763 |
|
|
2022
Q3 | $221K | Hold |
4,260
| – | – | 0.02% | 615 |
|
|
2022
Q2 | $201K | Hold |
4,260
| – | – | 0.02% | 649 |
|
|
2022
Q1 | $303K | Hold |
4,260
| – | – | 0.02% | 557 |
|
|
2021
Q4 | $319K | Buy |
+4,260
| New | +$319K | 0.02% | 568 |
|
|
2021
Q3 | – | Sell |
-4,780
| Closed | -$210K | – | 746 |
|
|
2021
Q2 | $210K | Hold |
4,780
| – | – | 0.02% | 684 |
|
|
2021
Q1 | $236K | Hold |
4,780
| – | – | 0.02% | 638 |
|
|
2020
Q4 | $201K | Hold |
4,780
| – | – | 0.02% | 651 |
|
|
2020
Q3 | $219K | Buy |
+4,780
| New | +$219K | 0.02% | 562 |
|
|
2019
Q3 | – | Sell |
-2,990
| Closed | -$252K | – | 653 |
|
|
2019
Q2 | $252K | Hold |
2,990
| – | – | 0.04% | 474 |
|
|
2019
Q1 | $286K | Buy |
+2,990
| New | +$286K | 0.05% | 427 |
|